sb 203580 has been researched along with Hepatitis, Viral, Animal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beauchemin, N; Bleau, C; Jacques, A; Lamontagne, L; Turbide, C | 1 |
1 other study(ies) available for sb 203580 and Hepatitis, Viral, Animal
| Article | Year |
|---|---|
A synergistic interferon-gamma production is induced by mouse hepatitis virus in interleukin-12 (IL-12)/IL-18-activated natural killer cells and modulated by carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1a receptor.
Topics: Acute Disease; Animals; Butadienes; Carcinoembryonic Antigen; Cell Line; Cells, Cultured; Enzyme Inhibitors; Fibroblasts; Hepatitis, Viral, Animal; Imidazoles; Interferon-gamma; Interleukin-12; Interleukin-18; Killer Cells, Natural; Leukocytes, Mononuclear; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase Kinases; Murine hepatitis virus; Nitriles; Pyridines; Recombinant Proteins | 2009 |